PBL InterferonSource and Quansys Biosciences have entered into an agreement to broaden Quansys’ Q-Plex multiplex array offerings to enable the detection of interferons. This combination will allow researchers to examine the relationship of multiple interferons and cytokines simultaneously. Using this assay platform, researchers in autoimmunity and infectious disease can address key questions in drug development and clinical research. These include assessing cytokine profiles at various points throughout the course of disease, correlating alterations in cytokine profiles with patient responses to therapies, and determining off-target effects of drugs. Quansys Biosciences, Inc., 888-782-6797, www.quansysbio.com; PBL InterferonSource, 877-725-8881, www.interferonsource.com